Disulfiram should never be taken while intoxicated or without a patient's full knowledge. Alcohol must be avoided before starting, during treatment, and for up to 14 days after the last dose because reactions can continue after medication is stopped.
Disulfiram is not a cure for alcohol use disorder and does not directly treat withdrawal. It is usually strongest when paired with counseling, recovery planning, accountability, follow-up, and treatment for anxiety, depression, insomnia, trauma, or other co-occurring conditions when those are present.
Choose an alcohol-treatment location you can return to for safety and progress reviews. A disulfiram evaluation should assess whether this medicine fits your goal of abstinence, recent drinking, health history and ability to avoid alcohol. Ask the intended site whether it provides that evaluation and follow-up, then confirm the pharmacy and counseling plan.
Bring your medication and product list, recent lab results if available, previous alcohol-treatment or discharge records and a clear description of drinking and withdrawal symptoms. Tell the clinician about liver disease, heart disease, psychiatric symptoms, pregnancy questions and other substances. Starting disulfiram requires informed consent and an individualized safety assessment; it should never be given secretly or while someone is intoxicated.
If disulfiram is appropriate, confirm where the prescription will be filled and how liver monitoring and side-effect review will occur. Ask about medication costs separately from the visit. Discuss who to contact about a missed tablet, suspected reaction, jaundice or renewed drinking. A nearby location alone does not establish a current prescription or pharmacy supply.
Disulfiram does not directly treat cravings or acute withdrawal. Discuss counseling, relapse prevention and any agreed support for adherence. A trusted person can help only with your knowledge and agreement. Ask which follow-up visits may be virtual and which need local assessment or testing. Confirm the next contact before leaving.
Avoid alcohol during treatment and for the specified period after the last dose; label precautions extend reaction risk for up to 14 days. Review hidden alcohol in medicines and other products with the clinician. A severe reaction, chest pain, collapse, trouble breathing, seizure or confusion needs emergency care. Dangerous alcohol withdrawal requires an appropriate withdrawal service rather than waiting for a medication appointment.
Disulfiram is an alcohol-deterrent medicine for selected patients who want to avoid alcohol. Antabuse is a familiar brand name for the same active medicine. It is different from medicines aimed mainly at cravings: drinking while it remains active can cause a serious physical reaction. Choosing it requires informed agreement, a practical alcohol-avoidance plan and medical follow-up.
Disulfiram interferes with alcohol breakdown, causing acetaldehyde to accumulate if alcohol is consumed. The reaction can include flushing, vomiting and a racing heart, and severe reactions can be life-threatening. It does not remove alcohol from the body, treat intoxication or manage alcohol withdrawal. It should never be given secretly or used to punish or control another person’s drinking.
The evaluation considers readiness for abstinence, recent alcohol use and withdrawal risk. The clinician reviews liver and heart disease, psychiatric history, pregnancy, allergies and interacting medicines. Severe myocardial disease or coronary occlusion, psychoses and certain medicines such as metronidazole or paraldehyde are important label exclusions. Being interested in a prescription is not enough if alcohol exposure or unsafe withdrawal makes the plan unsuitable.
Describe the last drink, usual drinking pattern, past withdrawal, seizures and detox treatment. The clinician determines when a start is appropriate. If significant withdrawal is likely, medical withdrawal care comes first; disulfiram cannot substitute for it.
Review what an alcohol reaction can feel like, why it can be dangerous and how long the risk lasts after stopping. Discuss medicines, foods and household products that may contain alcohol. A family member may support your plan with your agreement, but cannot administer the medicine without your knowledge.
Bring liver test results if available and ask about baseline and early follow-up monitoring. Review how the prescribed tablet will fit your day and whether agreed support would help you take it reliably. A clinician should explain missed doses; do not take extra tablets to make a deterrent stronger.
Discuss cravings, stress, sleep, mental health and drinking triggers. Counseling, recovery support or another AUD medicine may be part of the plan. If you think you may drink, contact the team before a crisis rather than testing the reaction.
Bring a complete medication and supplement list, alcohol-containing remedies you use, treatment records and relevant heart or liver history. Ask a pharmacist about unclear labels on cough products, mouthwash, sauces or other products. Do not assume cooking removes all alcohol or that a product marketed as alcohol-free is safe without checking its content. Discuss an emergency plan and how to explain disulfiram use to another treating clinician.
The boxed warning says not to administer disulfiram during alcohol intoxication or without the patient’s full knowledge. Alcohol reactions can occur for up to fourteen days after the last tablet. Do not deliberately test drinking on it. Seek emergency care for chest pain, trouble breathing, collapse, marked confusion or severe symptoms after possible alcohol exposure. Disulfiram can also cause liver injury without a drinking reaction. Report jaundice, dark urine, loss of appetite or persistent nausea promptly. New numbness, vision problems or major mental-health changes also need review.
Follow-up reviews alcohol exposure, tablet adherence, cravings, adverse effects and liver monitoring. Missing tablets or stopping does not immediately remove reaction risk. Tell the prescriber if avoiding hidden alcohol is becoming difficult or if the plan feels coercive. Discuss a change in treatment rather than quietly stopping to drink. The decision to continue depends on safety, goals and whether the medicine is helping.
Ask whether the prescription will be filled as generic disulfiram and whether the named brand is available through your pharmacy; the pharmacy must confirm the actual product and supply. Clarify the costs of visits, laboratory monitoring and medication. Confirm who will follow up on test results and whom to contact before starting if alcohol was used after the visit was scheduled.
Nao Medical Crown Heights: 341 Eastern Pkwy, Brooklyn, NY 11216. Call +1-917-310-3371 to confirm the specific service, clinician and appointment before travelling.
Contact the clinic to confirm this service, the clinician and appointment preparation. General clinic hours may differ from service appointment times.
Contact the exact service and clinic to confirm the qualified clinician, evaluation modality and available treatment pathway. An electronic prescription, when clinically appropriate, goes to the agreed pharmacy; confirm that pharmacy’s fill and stock status separately. Describe a medication gap promptly and keep the current prescriber involved until responsibility is clear.
The current public clinic record lists 341 Eastern Pkwy, Brooklyn, NY 11216. Confirm the requested service, clinician capability, appointment and any medication delivery at this exact site before traveling. A clinic address does not establish that it administers every treatment.
Do not take disulfiram while intoxicated or without the prescriber’s plan; the label requires at least 12 hours after the last alcohol use before starting. Alcohol can cause a severe reaction, including through some medicines or other alcohol-containing products. A reaction can occur for up to 14 days after the last dose, so stopping the tablet is not permission to drink. Disulfiram is not alcohol detox or a cure; withdrawal safety and ongoing behavioral support still matter.
The evaluation considers readiness for abstinence, recent alcohol use and withdrawal risk. The clinician reviews liver and heart disease, psychiatric history, pregnancy, allergies and interacting medicines. Severe myocardial disease or coronary occlusion, psychoses and certain medicines such as metronidazole or paraldehyde are important label exclusions. Being interested in a prescription is not enough if alcohol exposure or unsafe withdrawal makes the plan unsuitable.
Describe the last drink, usual drinking pattern, past withdrawal, seizures and detox treatment. The clinician determines when a start is appropriate. If significant withdrawal is likely, medical withdrawal care comes first; disulfiram cannot substitute for it.
Review what an alcohol reaction can feel like, why it can be dangerous and how long the risk lasts after stopping. Discuss medicines, foods and household products that may contain alcohol. A family member may support your plan with your agreement, but cannot administer the medicine without your knowledge.
Bring liver test results if available and ask about baseline and early follow-up monitoring. Review how the prescribed tablet will fit your day and whether agreed support would help you take it reliably. A clinician should explain missed doses; do not take extra tablets to make a deterrent stronger.
Discuss cravings, stress, sleep, mental health and drinking triggers. Counseling, recovery support or another AUD medicine may be part of the plan. If you think you may drink, contact the team before a crisis rather than testing the reaction.
The boxed warning says not to administer disulfiram during alcohol intoxication or without the patient’s full knowledge. Alcohol reactions can occur for up to fourteen days after the last tablet. Do not deliberately test drinking on it. Seek emergency care for chest pain, trouble breathing, collapse, marked confusion or severe symptoms after possible alcohol exposure. Disulfiram can also cause liver injury without a drinking reaction. Report jaundice, dark urine, loss of appetite or persistent nausea promptly. New numbness, vision problems or major mental-health changes also need review.
Do not assume that cooking removes all alcohol. Alcohol in food, medicines and other products can cause a reaction. Review labels and ask the pharmacist or prescriber about uncertain products. Forum reports of a tolerated amount cannot establish a safe threshold.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View local alcohol treatment Get directions
Queens
37-15 23rd Ave, Astoria, NY 11105
A Queens access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
View local alcohol treatment Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View local alcohol treatment Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View local alcohol treatment Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View local alcohol treatment Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View local alcohol treatment Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A Queens access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View local alcohol treatment Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View local alcohol treatment Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View local alcohol treatment Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for alcohol-use-disorder medication evaluation, follow-up planning, and confidential care for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View local alcohol treatment Get directions